Effexor XR Follow-On Desvenlafaxine NDA Submitted
This article was originally published in The Pink Sheet Daily
Executive Summary
Assuming a standard FDA review, desvenlafaxine could be brought to market more than three years before Effexor XR faces generic competition.
You may also be interested in...
Wyeth’s Desvenlafaxine Advisory Committee Is Cancelled
FDA determines that its questions have been satisfactorily answered.
Wyeth’s Desvenlafaxine Advisory Committee Is Cancelled
FDA determines that its questions have been satisfactorily answered.
Teva’s Effexor Generic Launches Following ANDA Approval
Teva began shipping the generic of Wyeth's antidepressant Aug. 4.